Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2gQqN2T
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Neonatal-Onset Multisystem Inflammatory Disease (NOMID) or Chronic Infantile Neurologic Cutaneous Articular (CINCA) syndrome is a...
-
Resuscitation from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1polruV
-
from EMS via xlomafota13 on Inoreader http://ift.tt/1VEcmwT
-
Resuscitation from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1N8kkFN
-
The American Journal of Emergency Medicine from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1VLdEFJ
-
Pharmaceutical shortages are an ongoing challenge for EMS providers, but agencies can take proactive steps to address the issue from EMS v...
-
Abstract Indolent B cell lymphomas are a group of lymphoid malignancies characterized by their potential to undergo histologic transformat...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου